Europe Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

April 2023 | 198 pages | ID: E7205C2046FAEN
GMD Research

Abstracts

Europe active pharmaceutical ingredients (API) market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.

Highlighted with 91 tables and 76 figures, this 198-page report “Europe Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe active pharmaceutical ingredients (API) market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

Based on Molecule, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Small Molecule APIs
• Large Molecule APIs

Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Synthetic API
• Branded Synthetic API
• Generic Synthetic API
• Biotech API
• by type
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Other Biotech APIs
• by Category
• Innovative Biologic API
• Generic Biosimilar API
• by Expression
• Mammalian Expression
• Microbial Expression
• Yeast Expression
• Insect Expression
• Other Expression Technologies
• HPAPI
• Branded HPAPI
• Generic HPAPI

Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Captive Manufacturing
• Branded Captive API
• Generic Captive API
• Merchant Manufacturing
• by Drug Type
• Branded Merchant API
• Generic Merchant API
• by Drug Synthesis
• Merchant Synthetic API
• Merchant Biotech API

By Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications

By Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

AbbVie Inc.

Astrazeneca

Aurobindo Pharma Ltd.

BASF

Bayer AG

Boehringer Ingelheim

Catalent Inc.

Dr. Reddy's Laboratories

F. Hoffmann-La Roche

GlaxoSmithKline plc

Lonza Group

Lupin Limited

Merck & Co., Inc.

Mylan NV

Novartis International AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY MOLECULE

3.1 Market Overview by Molecule
3.2 Small Molecule APIs
3.3 Large Molecule APIs

4 SEGMENTATION OF EUROPE MARKET BY SYNTHESIS

4.1 Market Overview by Synthesis
4.2 Synthetic API
  4.2.1 Branded Synthetic API
  4.2.2 Generic Synthetic API
4.3 Biotech API
  4.3.1 Biotech API by Drug Type
    4.3.1.1 Monoclonal Antibodies
    4.3.1.2 Recombinant Proteins
    4.3.1.3 Vaccines
    4.3.1.4 Other Biotech APIs
  4.3.2 Biotech API by Category
    4.3.2.1 Innovative Biologic API
    4.3.2.2 Generic Biosimilar API
  4.3.3 Biotech API by Expression Technology
    4.3.3.1 Mammalian Expression
    4.3.3.2 Microbial Expression
    4.3.3.3 Yeast Expression
    4.3.3.4 Insect Expression
    4.3.3.5 Other Expression Technologies
4.4 HPAPI
  4.4.1 Branded HPAPI
  4.4.2 Generic HPAPI

5 SEGMENTATION OF EUROPE MARKET BY MANUFACTURING PROCESS

5.1 Market Overview by Manufacturing Process
5.2 Captive Manufacturing
  5.2.1 Branded Captive API
  5.2.2 Generic Captive API
5.3 Merchant Manufacturing
  5.3.1 Merchant Manufacturing by Drug Type
    5.3.1.1 Branded Merchant API
    5.3.1.2 Generic Merchant API
  5.3.2 Merchant Manufacturing by Drug Synthesis
    5.3.2.1 Merchant Synthetic API
    5.3.2.2 Merchant Biotech API

6 SEGMENTATION OF EUROPE MARKET BY THERAPEUTIC APPLICATION

6.1 Market Overview by Therapeutic Application
6.2 Infectious Diseases
6.3 Oncology
6.4 Ophthalmology
6.5 Cardiovascular Disorders
6.6 Central Nervous System
6.7 Pulmonary Disorders
6.8 Orthopedics
6.9 Other Applications

7 SEGMENTATION OF EUROPE MARKET BY DRUG TYPE

7.1 Market Overview by Drug Type
7.2 Branded Prescription Drugs
7.3 Generic Prescription Drugs
7.4 OTC Drugs

8 EUROPEAN MARKET 2022-2032 BY COUNTRY

8.1 Overview of European Market
8.2 UK
8.3 France
8.4 Germany
8.5 Spain
8.6 Italy
8.7 Russia
8.8 Rest of European Market

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Related Reports and Products

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Europe Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 7. Main Product Trends and Market Opportunities in Europe Active Pharmaceutical Ingredients (API) Market
Table 8. Europe Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn
Table 9. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 10. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn
Table 11. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn
Table 12. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn
Table 13. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn
Table 14. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn
Table 15. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 16. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn
Table 17. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn
Table 18. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn
Table 19. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 20. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn
Table 21. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 22. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 23. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 24. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 25. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 26. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 27. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 28. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 29. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 30. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 31. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 32. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 33. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 34. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 35. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 36. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 37. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 38. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 39. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 40. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn
Table 41. AbbVie Inc.: Company Snapshot
Table 42. AbbVie Inc.: Business Segmentation
Table 43. AbbVie Inc.: Product Portfolio
Table 44. Astrazeneca: Company Snapshot
Table 45. Aurobindo Pharma Ltd.: Company Snapshot
Table 46. Aurobindo Pharma Ltd.: Product Portfolio
Table 47. BASF: Company Snapshot
Table 48. BASF: Business Segmentation
Table 49. Bayer AG: Company Snapshot
Table 50. Bayer AG: Business Segmentation
Table 51. Bayer AG: Product Portfolio
Table 52. Boehringer Ingelheim: Company Snapshot
Table 53. Boehringer Ingelheim: Product Portfolio
Table 54. Catalent Inc.: Company Snapshot
Table 55. Catalent Inc.: Business Segmentation
Table 56. Catalent Inc.: Product Portfolio
Table 57. Dr. Reddy's Laboratories: Company Snapshot
Table 58. Dr. Reddy's Laboratories: Business Segmentation
Table 59. F. Hoffmann-La Roche: Company Snapshot
Table 60. F. Hoffmann-La Roche: Clinical Trial Service
Table 61. F. Hoffmann-La Roche: Business Segmentation
Table 62. F. Hoffmann-La Roche: Revenue by Region
Table 63. GlaxoSmithKline: Company Snapshot
Table 64. GlaxoSmithKline: Business Segmentation
Table 65. GlaxoSmithKline: Product Portfolio
Table 66. Lonza Group: Company Snapshot
Table 67. Lonza Group: Business Segmentation
Table 68. Lonza Group: Product Portfolio
Table 69. Lupin Limited: Company Snapshot
Table 70. Lupin Limited: Business Segmentation
Table 71. Merck & Co., Inc.: Company Snapshot
Table 72. Merck & Co., Inc.: Business Segmentation
Table 73. Mylan NV: Company Snapshot
Table 74. Mylan NV: Breakdown of Revenue by Region, 2022
Table 75. Mylan NV: Breakdown of Revenue by Product Category, 2022
Table 76. Novartis International AG: Company Snapshot
Table 77. Novartis International AG: Business Segmentation
Table 78. Pfizer Inc.: Company Snapshot
Table 79. Pfizer Inc.: Business Segmentation
Table 80. Pfizer Inc.: Breakdown of Revenue by Product Category
Table 81. Pfizer Inc.: Breakdown of Revenue by Region
Table 82. Pfizer Inc.: Product Portfolio
Table 83. Sanofi: Company Snapshot
Table 84. Sanofi: Business Segmentation
Table 85. Sanofi: Breakdown of Revenue by Region
Table 86. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 87. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 88. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 89. Thermo Fisher Scientific: Company Snapshot
Table 90. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, %
Table 91. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, %

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Europe Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market
Figure 7. GDP per capita in the World, 1960-2022, $ thousand
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Europe Active Pharmaceutical Ingredients (API) Market
Figure 14. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue
Figure 15. Europe Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%)
Figure 16. Europe Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn
Figure 17. Europe Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn
Figure 18. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue
Figure 19. Contribution to Europe 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)
Figure 20. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn
Figure 21. Europe Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn
Figure 22. Europe Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn
Figure 23. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn
Figure 24. Europe Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn
Figure 25. Europe Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn
Figure 26. Europe Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn
Figure 27. Europe Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn
Figure 28. Europe Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn
Figure 29. Europe Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn
Figure 30. Europe Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn
Figure 31. Europe Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn
Figure 32. Europe Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn
Figure 33. Europe Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn
Figure 34. Europe Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn
Figure 35. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn
Figure 36. Europe Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn
Figure 37. Europe Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn
Figure 38. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue
Figure 39. Contribution to Europe 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)
Figure 40. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn
Figure 41. Europe Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn
Figure 42. Europe Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn
Figure 43. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn
Figure 44. Europe API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn
Figure 45. Europe API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn
Figure 46. Europe API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn
Figure 47. Europe API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn
Figure 48. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue
Figure 49. Contribution to Europe 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 50. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn
Figure 51. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn
Figure 52. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn
Figure 53. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn
Figure 54. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn
Figure 55. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn
Figure 56. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn
Figure 57. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn
Figure 58. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue
Figure 59. Contribution to Europe 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 60. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn
Figure 61. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn
Figure 62. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn
Figure 63. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 64. Contribution to Europe 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 65. Active Pharmaceutical Ingredients (API) Market in UK, 2022-2032, $ bn
Figure 66. Active Pharmaceutical Ingredients (API) Market in France, 2022-2032, $ bn
Figure 67. Active Pharmaceutical Ingredients (API) Market in Germany, 2022-2032, $ bn
Figure 68. Active Pharmaceutical Ingredients (API) Market in Spain, 2022-2032, $ bn
Figure 69. Active Pharmaceutical Ingredients (API) Market in Italy, 2022-2032, $ bn
Figure 70. Active Pharmaceutical Ingredients (API) Market in Russia, 2022-2032, $ bn
Figure 71. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2022-2032, $ bn
Figure 72. Growth Stage of Europe Active Pharmaceutical Ingredients (API) Industry over the Forecast Period
Figure 73. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022
Figure 74. AstraZeneca: Breakdown of Revenue by Region, 2022
Figure 75. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022
Figure 76. Boehringer Ingelheim: R&D Investement, 2019-2022